Dr Junwen Zhou
BSc, MSc, PhD
Junwen Zhou joined HERC in October 2020 as Senior Researcher. Junwen’s current work focuses on economic analysis and modelling of chronic diseases using individual participant data from large randomised controlled trials and observational data with focus on cardiovascular disease prevention.
Junwen received his PhD in Clinical Research and Public Health from Aix-Marseille University, France, with thesis focusing on economic modelling with discrete event simulation (DES) in schizophrenia. He received his MSc in Clinical Pharmacy from Peking University, China, with thesis focusing on evidence synthesis with network meta-analysis (NMA) in osteoporosis. He received his BSc in Pharmacy with dual degree in Economics from Peking University, China.
Junwen is experienced in health economic evaluation methods and applications. Prior to his current position, he worked as Modelling Lead in Global Health Economic and Value Assessment (HEVA) in Sanofi, France. Before that, he worked as Research Analyst, then Senior Analyst in Health Economic and Outcome Research (HEOR) in Creativ-Ceutical, France. He also has clinical experience, worked as Clinical Pharmacist Intern in Peking University Third Hospital, China.
Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
Wu R. et al, (2023), British Journal of General Practice
A systematic review of the factors associated with suicide attempts among sexual-minority youth
Wang XX. et al, (2023), The European Journal of Psychiatry, 37, 72 - 83
Cost-effectiveness of endovascular thrombectomy with alteplase versus endovascular thrombectomy alone for acute ischemic stroke secondary to large vessel occlusion.
Ye Z. et al, (2023), CMAJ Open, 11, E443 - E450
Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis.
Wang K. et al, (2023), Front Aging Neurosci, 15
Prediction models for individual-level healthcare costs associated with cardiovascular events in the UK
Zhou J. et al, (2022), PharmacoEconomics